Deciphering stromal cell interactions in osteosarcoma highlights CDKN2A and MMP14 as novel diagnostic and therapeutic biomarkers

Key Points

• Stromal cell interactions reveal CDKN2A and MMP14 as potential biomarkers for osteosarcoma, enhancing diagnostic capabilities.
• The analysis identifies specific cellular interactions, showing the significance of these biomarkers in cancer pathology.
• Assessment of stromal cells and their role in tumor microenvironments underscores the importance of targeted therapies.
• Identifying CDKN2A and MMP14 could lead to novel treatment strategies, requiring further validation in clinical settings.